Lack of citalopram effect on oral digoxin pharmacokinetics

Journal of Clinical Pharmacology

Volumn 41, Issue 3, 2001, Pages 340-346

  Larsen, Frank ^a   Priskorn, Morten ^a,b   Overø, Kerstin Fredricson ^a  

^a H LUNDBECK A S   (Denmark)

^b NEUROSEARCH A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; DIGOXIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG TOLERABILITY; ELECTROCARDIOGRAM; FEMALE; HUMAN; MALE; NORMAL HUMAN; SIDE EFFECT; URINALYSIS;

ADMINISTRATION, ORAL; ADULT; CARDIOTONIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITALOPRAM; CROSS-OVER STUDIES; DIGOXIN; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EATING; FASTING; FEMALE; HUMANS; MALE; RADIOIMMUNOASSAY; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 0035127529     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912700122010041     Document Type: Article

References (22)

1. Citalopram in doses of 20-60 mg is effective in depression relapse prevention: A placebo-controlled 6 month study
2. Multicenter, placebo-controlled, fixed dose study of citalopram in moderate to severe depression
3. Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia
4. Citalopram: A review of its pharmacology, clinical efficacy and tolerability in the treatment of depression
5. Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms
6. Identification of cytochrome p450 isoforms involved in citalopram N-demethylation by human liver microsomes
7. Drug interactions with newer antidepressants: Role of human cytochromes P450
8. Citalopram and desmethylcitalopram in vitro: Human cytochromes mediating transformation, and cytochrome inhibitory effects
9. Digitalis toxicity
10. Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose
11. The pharmacokinetics of citalopram
12. High-performance liquid chromatographic determination of citalopram and four of its metabolites in plasma and urine samples from psychiatric patients
13. Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin
14. Elevated serum digoxin level associated with coadministered fluoxetine
15. Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans
16. Investigation of multiple dose citalopram on the pharmacokinetics and pharmacodynamics of racemic warfarin
17. Cardiac safety of citalopram: Prospective trials and retrospective analyses
18. Adverse event profile of citalopram in the elderly
19. Comparison of adverse events between citalopram and other selective serotonin reuptake inhibitors